Mode
Text Size
Log in / Sign up

Lung cancer incidence decreased more in metropolitan than nonmetropolitan US counties from 2007-2016

Lung cancer incidence decreased more in metropolitan than nonmetropolitan US counties from 2007-2016
Photo by Dmytro Vynohradov / Unsplash
Key Takeaway
Note an observational disparity in lung cancer incidence trends between US county types from 2007-2016.

An observational study examined lung cancer incidence rates across United States counties from 2007 to 2016. The analysis compared trends in metropolitan and nonmetropolitan counties, though the specific sample size was not reported. The primary outcome was the change in lung cancer incidence rates over this decade.

The main finding was that lung cancer incidence rates decreased more in metropolitan counties than in nonmetropolitan counties. The study did not report the magnitude of this difference (effect size), absolute numbers, or statistical measures such as p-values or confidence intervals. The direction of change was a decrease in both areas, with a greater decrease observed in metropolitan regions.

No safety or tolerability data were reported, as this was a population-level incidence study. Key limitations include the observational nature of the data, which can only show association, not causation. The analysis did not explore potential reasons for the disparity, such as differences in smoking rates, screening access, or diagnostic practices. The findings are relevant for recognizing a persistent geographic disparity in lung cancer trends over a specific period in the US, but they cannot guide specific clinical interventions without understanding the underlying drivers.

Study Details

EvidenceLevel 5
PublishedNov 2019
View Original Abstract ↓
During 2007-2016, lung cancer incidence rates decreased more in metropolitan than nonmetropolitan counties.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.